CN119584872A - 封入有烟酰胺单核苷酸的用于改善肠道菌群的肠溶性胶囊制剂 - Google Patents

封入有烟酰胺单核苷酸的用于改善肠道菌群的肠溶性胶囊制剂 Download PDF

Info

Publication number
CN119584872A
CN119584872A CN202380054931.7A CN202380054931A CN119584872A CN 119584872 A CN119584872 A CN 119584872A CN 202380054931 A CN202380054931 A CN 202380054931A CN 119584872 A CN119584872 A CN 119584872A
Authority
CN
China
Prior art keywords
intestinal flora
enteric capsule
capsule preparation
enteric
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380054931.7A
Other languages
English (en)
Chinese (zh)
Inventor
田中惠
田中经丸
北野宏明
谷内江绫子
萨米可·高希
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN119584872A publication Critical patent/CN119584872A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/20—Ingredients acting on or related to the structure
    • A23V2200/224—Encapsulating agent
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202380054931.7A 2022-07-21 2023-07-21 封入有烟酰胺单核苷酸的用于改善肠道菌群的肠溶性胶囊制剂 Pending CN119584872A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022116167 2022-07-21
JP2022-116167 2022-07-21
PCT/JP2023/026741 WO2024019141A1 (ja) 2022-07-21 2023-07-21 ニコチンアミドモノヌクレオチドが封入されている腸内細菌叢改善用腸溶性カプセル剤

Publications (1)

Publication Number Publication Date
CN119584872A true CN119584872A (zh) 2025-03-07

Family

ID=89617960

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380054931.7A Pending CN119584872A (zh) 2022-07-21 2023-07-21 封入有烟酰胺单核苷酸的用于改善肠道菌群的肠溶性胶囊制剂

Country Status (6)

Country Link
US (1) US20260027144A1 (cg-RX-API-DMAC7.html)
EP (1) EP4559327A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2024019141A1 (cg-RX-API-DMAC7.html)
KR (1) KR20250038714A (cg-RX-API-DMAC7.html)
CN (1) CN119584872A (cg-RX-API-DMAC7.html)
WO (1) WO2024019141A1 (cg-RX-API-DMAC7.html)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
JP2007112805A (ja) * 2002-07-22 2007-05-10 Meito Sangyo Co Ltd ラクトバシラス・カゼイ亜種カゼイ増殖促進用組成物
US20160346303A1 (en) * 2014-10-29 2016-12-01 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
KR20180046692A (ko) * 2016-10-28 2018-05-09 롯데제과 주식회사 과민성 대장증후군 개선용 조성물
JP7128459B2 (ja) 2017-11-15 2022-08-31 株式会社神鋼環境ソリューション 腸内細菌叢改善剤
KR102205195B1 (ko) 2018-01-23 2021-01-20 주식회사 네패스 반도체 칩 적층 패키지 및 그 제조 방법
JP2019170335A (ja) 2018-03-29 2019-10-10 焼津水産化学工業株式会社 腸内短鎖脂肪酸生成促進組成物
WO2020166527A1 (ja) * 2019-02-12 2020-08-20 めぐみ 田中 乳幼児用飲食品、乳幼児の腸内環境の改善方法、及び乳幼児の免疫力の増強方法
JP7488556B2 (ja) * 2020-06-15 2024-05-22 株式会社山田養蜂場本社 細菌の腸内における数を調整するための剤、腸内代謝物質量調整剤、及び便通改善剤
CN111617064A (zh) * 2020-06-24 2020-09-04 渤海大学 大豆种皮多糖在制备调节肠道菌群、降糖降脂以及抗炎症的药物和特医食品中的应用
CN112386581A (zh) * 2020-09-24 2021-02-23 赫曼因生物科技有限公司 一种抗酸肠溶nmn胶囊的包衣配方
CN112089775A (zh) * 2020-10-30 2020-12-18 成都及禾生物科技有限公司 一种nmn有益菌健康组合物及其制备方法和应用
CN112972426A (zh) * 2021-02-23 2021-06-18 成都西域从容生物科技有限公司 一种含nmn的胶囊及其制备方法
CN113633626B (zh) * 2021-07-28 2022-09-27 山东润德生物科技有限公司 一种nmn的胶囊包衣及nmn胶囊制备方法与应用

Also Published As

Publication number Publication date
WO2024019141A1 (ja) 2024-01-25
KR20250038714A (ko) 2025-03-19
US20260027144A1 (en) 2026-01-29
EP4559327A1 (en) 2025-05-28
EP4559327A4 (en) 2026-07-08
JPWO2024019141A1 (cg-RX-API-DMAC7.html) 2024-01-25

Similar Documents

Publication Publication Date Title
US11696921B2 (en) Synthetic composition for microbiota modulation
AU2025204134A1 (en) Probiotic bacterial strains that produce short chain fatty acids and compositions comprising same
JP2017132815A (ja) プレバイオティック製剤および使用方法
KR20200091438A (ko) 미생물총 조절을 위한 인간 밀크 올리고당 및 그의 합성 조성물
CN109419816B (zh) 解纤维素拟杆菌在预防和/或治疗心脏疾病方面的应用
CN106994134B (zh) 肠道益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
CN106852938A (zh) 拟杆菌(Bacteroides)在治疗和预防肥胖相关疾病中的应用
WO2019041140A1 (zh) 沙氏别样杆菌在制备预防和/或治疗脂质代谢性相关疾病组合物中的应用
CN107028985A (zh) 厚壁菌类益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
US20090311227A1 (en) Composition
EP3721889B1 (en) Butyribacter intestini for use in preventing and/or treating inflammatory bowel disease
US20260027144A1 (en) Enteric capsule for improving intestinal bacterial flora encapsulating nicotinamide mononucleotide
WO2022091075A1 (en) Combination compositions of probiotics with fermented wheat germ extract and uses thereof
WO2020113580A1 (zh) 人粪厌氧棒形菌在预防和/或治疗代谢性疾病中的用途
CN106974940B (zh) 厚壁菌类益生菌在治疗和预防肥胖及其相关疾病中的应用
CN107080756B (zh) 链球菌属益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
CN110831608A (zh) 预防疾病的合生素组合物
HK1240096A (en) Application of intestinal probiotics in preventing and/or treating diabetes and related diseases thereof
HK1240096A1 (en) Application of intestinal probiotics in preventing and/or treating diabetes and related diseases thereof
JP2026028210A (ja) ビフィドバクテリウム・ロンガム及びその血中のトリメチルアミンオキシドの減少、腸内のアッカーマンシアムシニフィラの含有量の増加のための使用
HK1240143A (en) Application of thick-wall fungus probiotics in preventing and/or treating diabetes and related diseases thereof
HK1240131A (en) Use of streptococcus probiotics in the prevention and/or treatment of diabetes and related diseases
HK1240143A1 (en) Application of thick-wall fungus probiotics in preventing and/or treating diabetes and related diseases thereof
HK1240131A1 (en) Use of streptococcus probiotics in the prevention and/or treatment of diabetes and related diseases
HK1240096B (en) Application of intestinal probiotics in preventing and/or treating diabetes and related diseases thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination